Sifalimumab
Encyclopedia
Sifalimumab is a human monoclonal antibody designed for the treatment of SLE
, dermatomyositis
, and polymyositis
.
Sifalimumab was developed by MedImmune
.
SLE
-Medicine:* Systemic lupus erythematosus, an autoimmune disease affecting multiple systems in the body* Slit lamp examination, as used to examine the eye during an eye examination* St...
, dermatomyositis
Dermatomyositis
Dermatomyositis is a connective-tissue disease related to polymyositis and Bramaticosis that is characterized by inflammation of the muscles and the skin.- Causes :...
, and polymyositis
Polymyositis
Polymyositis is a type of chronic inflammation of the muscles related to dermatomyositis and inclusion body myositis.-Signs and symptoms:...
.
Sifalimumab was developed by MedImmune
MedImmune
MedImmune, LLC, headquartered in Gaithersburg, Maryland, became a wholly owned subsidiary of AstraZeneca in 2007. Since being acquired, MedImmune has remained a Maryland-based biotechnology development enterprise...
.